Home › Atopic Dermatitis (Eczema)
Atopic Dermatitis (Eczema) clinical trials recruiting in the U.S.
62 studies for Atopic Dermatitis (Eczema) are recruiting participants at sites across the United States.
Cities with the most studies
- New York City, NY13 studies
- Los Angeles, CA11 studies
- Washington, DC11 studies
- San Diego, CA10 studies
- San Antonio, TX10 studies
- Birmingham, AL9 studies
- Miami, FL9 studies
- Huntington Beach, CA8 studies
- Sacramento, CA8 studies
- Dallas, TX8 studies
- Troy, MI8 studies
- Pittsburgh, PA7 studies
- Tampa, FL7 studies
- Indianapolis, IN7 studies
- Santa Monica, CA6 studies
- Philadelphia, PA6 studies
- Phoenix, AZ6 studies
- Santa Clarita, CA6 studies
- Chicago, IL6 studies
- Sugar Land, TX6 studies
- Portland, OR5 studies
- St. Petersburg, FL5 studies
- Charleston, SC5 studies
- Little Rock, AR5 studies
- Las Vegas, NV5 studies
- Cleveland, OH4 studies
- Coral Springs, FL4 studies
- San Francisco, CA4 studies
- Newton, MA4 studies
- Fremont, CA4 studies
- Baltimore, MD4 studies
- Fargo, ND4 studies
- Louisville, KY4 studies
- Arlington, TX4 studies
- Portsmouth, NH4 studies
- Ann Arbor, MI4 studies
- Morgantown, WV4 studies
- Harrisburg, PA4 studies
- Miami Gardens, FL4 studies
- Houston, TX3 studies
By state
- Alabama9 studies
- Arizona7 studies
- Arkansas8 studies
- California30 studies
- Colorado4 studies
- Florida18 studies
- Georgia9 studies
- Idaho4 studies
- Illinois10 studies
- Indiana9 studies
- Kentucky4 studies
- Maryland16 studies
- Massachusetts6 studies
- Michigan14 studies
- Missouri7 studies
- Nebraska4 studies
- Nevada6 studies
- New Hampshire5 studies
- New Jersey3 studies
- New York16 studies
- North Carolina8 studies
- North Dakota4 studies
- Ohio10 studies
- Oregon6 studies
- Pennsylvania13 studies
- South Carolina10 studies
- Texas18 studies
- Utah4 studies
- Virginia5 studies
- Washington3 studies
- West Virginia4 studies
Recently updated studies
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 72 · All sexes · Updated Sep 29, 2026 · NCT06808477Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 29, 2026 · NCT07453602Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RecruitingPhase 1
Ages 12 to 120 · All sexes · Updated Sep 29, 2026 · NCT07262983This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
RecruitingObservational study
Ages 12 and older · All sexes · Updated Sep 29, 2026 · NCT07290803Effects of Treatments on Atopic Dermatitis
RecruitingPhase 2Healthy volunteers welcome
Ages 2 to 50 · All sexes · Updated Sep 28, 2026 · NCT01631617Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Sep 25, 2026 · NCT07216027A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Sep 25, 2026 · NCT06807281First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07527923Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07003425Natural History and Genetics of Food Allergy and Related Conditions
RecruitingObservational studyHealthy volunteers welcome
1 Day – 99 Years · All sexes · Updated Sep 22, 2026 · NCT02504853Metabolic Profiling of Immune Responses in Immune-mediated Diseases
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT04864886Studies of Skin Microbes in Healthy People and in People With Skin Conditions
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 · All sexes · Updated Sep 16, 2026 · NCT00605878Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
RecruitingObservational study
Ages 12 to 89 · All sexes · Updated Sep 15, 2026 · NCT07645820The Impact of Dietary Salt on the Severity of Eczema
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07447063The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07487831Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Recruiting
Ages 13 to 17 · All sexes · Updated Sep 8, 2026 · NCT07746427A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 4, 2026 · NCT07765888A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07223697A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Sep 4, 2026 · NCT07355075A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT04504955Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
RecruitingPhase 2
Ages 3 to 21 · All sexes · Updated Aug 26, 2026 · NCT03835767Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
RecruitingObservational study
Ages 12 and older · All sexes · Updated Aug 17, 2026 · NCT06899204From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.